skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid

Preferred term

n-/{[(5-/{6-[(/{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy/}(hydroxy)phosphoryl)amino]-9h-purin-9-yl/}-4-hydroxyoxolan-2-yl)methoxy](hydroxy)phosphoryl/}-2,3-dihydroxy-4-methylpentanimidic acid  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C22H36N6O16P2

inchi

  • InChI=1S/C22H36N6O16P2/c1-8(2)13(32)15(34)20(36)27-45(37,38)41-5-9-3-10(30)21(42-9)28-7-25-12-18(23-6-24-19(12)28)26-46(39,40)44-22-16(35)14(33)17(43-22)11(31)4-29/h6-11,13-17,21-22,29-35H,3-5H2,1-2H3,(H2,27,36,37,38)(H2,23,24,26,39,40)

inchikey

  • FIMRCGIHIAIVOL-UHFFFAOYSA-N

mass

  • 702.504

monoisotopicmass

  • 702.16630

smiles

  • P(OC1OC(C(O)C1O)C(O)CO)(O)(=O)NC=2N=CN=C3N(C4OC(CC4O)COP(O)(=O)NC(=O)C(O)C(O)C(C)C)C=NC32

subset

  • 2_STAR

synonym EXACT

  • [5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy-N-[9-[5-[[[(2,3-dihydroxy-4-methylpentanoyl)amino]-hydroxyphosphoryl]oxymethyl]-3-hydroxyoxolan-2-yl]purin-6-yl]phosphonamidic acid

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:185499

Download this concept:

RDF/XML TURTLE JSON-LD